Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axatilimab vs BAT in Pediatric cGVHD (AGAVE-256)
NCT07124078Phase 2Recruiting
- Sponsor
- Incyte
- Start
- May 2026
- Primary completion
- Jan 2029
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of axatilimab in chronic graft-versus-host disease (cGVHD), sponsored by Incyte. Started May 2026; status: recruiting.
02
Drugs
axatilimab
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT07124078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07124078.